Fierce Healthcare

NOVEMBER 17, 2021

SCAN launches in-home, virtual primary care medical group. pminemyer. Wed, 11/17/2021 - 16:03.

144

144

pharmaphorum

NOVEMBER 19, 2021

The race to find and bring vaccines to market to fight Covid was impressive. So too are the sales figures. Katrina Megget reports. It’s been almost a year since the first Covid vaccine was authorised for use. The mRNA jab, developed by Pfizer and BioNTech, launched to huge fanfare in December 2020 and promised the start of the end of the coronavirus pandemic.

Vaccines 137

Vaccines Communication 137

Outsourcing Pharma

NOVEMBER 16, 2021

CRISPR Therapeutics and ViaCyte, Inc. have received the green light from Health Canada for their Clinical Trial Application for VCTX210: an allogeneic, gene-edited, immune-evasive, stem cell-derived therapy for the treatment of type 1 diabetes (T1D).

Immunization 111

Immunization 111

Fierce Pharma

NOVEMBER 15, 2021

A new way to access scientific papers? admin. Mon, 11/15/2021 - 12:01.

59

59

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Fierce Healthcare

NOVEMBER 19, 2021

Medicare startup EasyHealth gets $135M in series A to fill information gaps. rtorrence. Fri, 11/19/2021 - 10:10.

143

143

pharmaphorum

NOVEMBER 16, 2021

Amazon’s push into the provision of remote healthcare services has been rewarded with a top-tier corporate client – the Hilton hotel chain. The deal – first reported by Reuters – involves the Amazon Care platform, which includes remote, online consultations with clinicians, as well as home visits in some areas. It provides primary and preventive care, ongoing support for chronic conditions, and referrals to secondary and tertiary care.

Hospitals 133

Hospitals 133

Pharma Times

NOVEMBER 18, 2021

The UKHSA have said that deferring the vaccine dose could help to reduce even further the small risk of heart inflammation following vaccination

Vaccines 56

Vaccines 56

Fierce Healthcare

NOVEMBER 19, 2021

MedArrive nabs $25M to ramp up at-home health services, expand into new states. hlandi. Fri, 11/19/2021 - 16:56.

141

141

pharmaphorum

NOVEMBER 15, 2021

Johnson & Johnson’s SGLT2 inhibitor Invokana has been shown to have a significant effect on heart failure symptoms in a clinical trial that relied entirely on remote monitoring of symptoms using a smartphone app. The real-world CHIEF-HF study is said to be the first fully “decentralised, mobile, indication-seeking clinical study” with no need for patients to visit clinic, according to J&J’s pharma division Janssen.

Labelling 105

Labelling FDA 105

Outsourcing Pharma

NOVEMBER 17, 2021

According to data released by the company, the majority of study professionals plan to run agile or hybrid trials over the course of the next 12 months.

82

82

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharma Times

NOVEMBER 19, 2021

Vumerity is a next-generation oral fumarate treatment for adults with relapsing-remitting multiple sclerosis

54

54

Fierce Healthcare

NOVEMBER 18, 2021

Nursing startup nabs $149M for healthcare staffing platform. rtorrence. Thu, 11/18/2021 - 12:23.

138

138

pharmaphorum

NOVEMBER 16, 2021

Biogen’s chief medical officer Al Sandrock has announced he will retire at the end of the year, ending a 23-year career at the biotech. The architect of many of Biogen’s biggest-selling drugs, Sandrock is bowing out as Biogen is still struggling with the rollout of its controversial new Alzheimer’s disease therapy Aduhelm (aducanumab).

FDA 105

FDA 105

Outsourcing Pharma

NOVEMBER 15, 2021

The pharma company has completed enrollment of amyotrophic lateral sclerosis patients in its study investigating drugs like verdiperstat, an oral treatment.

69

69

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharma Times

NOVEMBER 15, 2021

Those eligible will have at least one F508del mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene

54

54

Fierce Healthcare

NOVEMBER 17, 2021

Healthfirst releases road map to addressing health equity, gaps in care. pminemyer. Wed, 11/17/2021 - 13:37.

138

138

pharmaphorum

NOVEMBER 19, 2021

Roche’s oral treatment Evrysdi for the rare genetic disease spinal muscular atrophy (SMA) will be made available on the NHS in England, after NICE reached a three-year access agreement with the company. The cost-effectiveness agency had turned down Evrysdi (risdiplam) in draft guidance published in June, saying it was too expensive, but after negotiations with Roche has reached a deal that will make the drug available to around 1,500 people in England.

98

98

Pharma Mirror

NOVEMBER 19, 2021

Amsterdam, CPhI Worldwide (9-11 November, 2021), which held its first in-person event since 2019, hosted the global pharma community at the Fiera Milano, Milan, welcoming exhibitors and attendees from 146 countries. This year’s smart event was a combination of a three-day live exhibition, and a month-long online event featuring both the latest market insights through live and on demand content sessions and of course networking opportunities.

52

52

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharma Times

NOVEMBER 19, 2021

Eligible adult patients with primary or secondary myelofibrosis will now be able to access the treatment on the NHS

54

54

Fierce Healthcare

NOVEMBER 16, 2021

Cigna study: How much behavioral health treatment can lower total cost of care. pminemyer. Tue, 11/16/2021 - 10:37.

137

137

pharmaphorum

NOVEMBER 18, 2021

Its vast experience in diabetes and the amount of data collected has propelled Novo Nordisk into exploring new modalities and searching for valuable collaborators, according to the company’s senior VP of global drug discovery Karin Conde-Knape. She discusses which therapeutic areas the company is gaining momentum in and how it aims to build its presence within these areas through external partnerships, in a session at the recent BIO-Europe with pharmaphorum’s founder Paul Tunnah.

98

98

Pharma Mirror

NOVEMBER 18, 2021

Shanghai, China’s pharma industry has seen a record improvement in its overall score, growth potential and biologics according to new data. The China specific findings of the CPhI Annual Report rankings[1] are released ahead of CPhI & P-MEC China – which will take place in hybrid form, with Virtual Expo Connect running digitally from November 18th until December 18th, and the in-person event held at the Shanghai New International Expo Center (SNIEC) December 16-18th, 2021.

52

52

Pharma Times

NOVEMBER 16, 2021

Treatment authorised for use in adults with COVID-19 who are at high-risk of progressing to severe disease

54

54

Fierce Healthcare

NOVEMBER 18, 2021

Experts weigh in on ways to combat growing antibiotic resistance amid COVID-19. agliadkovskaya. Thu, 11/18/2021 - 15:20.

136

136

pharmaphorum

NOVEMBER 18, 2021

Sanofi has made another investment in artificial intelligence, taking a $180 million equity stake in Franco-US startup Owkin with another $90 million in funding for a program to seek out new cancer therapies. The three-year project will focus on four types of cancer, and will deploy Owkin’s predictive biomedical AI models to find new biomarkers and therapeutic targets, as well as building models of the cancers and methods to predict if a patient will respond to a particular treatment.

Hospitals 98

Hospitals 98

Outsourcing Pharma

NOVEMBER 18, 2021

This monthâs launches, expanded facilities, partnerships, and other news includes items from Veeva, Hovione, Florence, Medidata, and other notable firms.

52

52

Pharma Times

NOVEMBER 16, 2021

Voluntary license agreement will allow generic versions of pill to be manufactured

52

52

Fierce Healthcare

NOVEMBER 17, 2021

Biden admin finalizes rule that requires insurers to submit data on drug costs, rebates. pminemyer. Wed, 11/17/2021 - 16:42.

Insurance 136

Insurance 136

pharmaphorum

NOVEMBER 16, 2021

Injectable antibodies targeting PCSK9 have failed to take off as expected in the cholesterol-lowering market, but Merck & Co hopes to do much better with an oral alternative. MK-0616 has been shown to reduce LDL cholesterol by a similar margin to injectables sold by Amgen and Sanofi/Regeneron – as well as Novartis’ longer-lasting RNAi therapy Leqvio – in two clinical trials reported at the American Heart Association (AHA) meeting.

FDA 98

FDA 98

SingleCare

NOVEMBER 17, 2021

Virtual doctor appointments — also called telemedicine or telehealth visits — are quickly becoming a popular method for getting a new prescription, obtaining refills, and managing medications. Through live video chat, telephone, email, secure messaging, or a mobile app, you can communicate with a provider and get prescriptions online for minor skin conditions, mental health concerns, and infectious conditions like the common cold or flu.

Mail-Order Pharmacies 52

Mail-Order Pharmacies Controlled Substances Health Insurance Companies Insurance 52

Pharma Times

NOVEMBER 15, 2021

Epilepsy affects over 600,000 people in the UK, which is approximately one in every 100 people

52

52

Fierce Healthcare

NOVEMBER 19, 2021

Avalere: Providers face 40% hit to Part B reimbursements under Dem drug price reforms. rking. Fri, 11/19/2021 - 15:04.

135

135

pharmaphorum

NOVEMBER 17, 2021

Biogen and Eisai have said that the EMA’s human medicines committee looks unlikely recommended approval of their Alzheimer’s drug Aduhelm when it comes up for discussion next month. The CHMP had a “negative trend vote” on the drug at a meeting last week which included an “oral explanation” of Aduhelm (aducanumab), which was approved in controversial circumstances by the US FDA earlier this year.

Hospitals 98

Hospitals FDA 98